tiprankstipranks
Trending News
More News >
Biofrontera (BFRI)
NASDAQ:BFRI
US Market

Biofrontera (BFRI) Financial Statements

Compare
197 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently $10.84M. The company's EPS TTM is $-0.62; its P/E ratio is -0.51; Biofrontera is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 37.30M$ 34.07M$ 28.67M$ 24.10M$ 18.85M
Gross Profit$ 18.70M$ 16.63M$ 13.49M$ 11.36M$ 9.78M
Operating Income$ -17.21M$ -22.68M$ -18.58M$ -25.20M$ -9.61M
EBITDA$ -14.44M$ -18.45M$ 934.00K$ -36.76M$ -7.46M
Net Income$ -17.76M$ -20.13M$ -640.00K$ -37.71M$ -10.99M
Balance Sheet
Cash & Short-Term Investments$ 5.91M$ 1.42M$ 27.76M$ 24.55M$ 8.08M
Total Assets$ 22.10M$ 27.93M$ 50.88M$ 53.22M$ 24.14M
Total Debt$ 4.92M$ 5.40M$ 1.35M$ 0.00$ 0.00
Net Debt$ -983.00K$ 4.06M$ -15.86M$ -24.55M$ -8.08M
Total Liabilities$ 17.67M$ 23.14M$ 27.01M$ 41.88M$ 18.31M
Stockholders' Equity$ 4.43M$ 4.79M$ 23.88M$ 11.34M$ 5.83M
Cash Flow
Free Cash Flow$ -10.33M$ -24.90M$ -16.24M$ -26.73M$ -12.37M
Operating Cash Flow$ -10.27M$ -24.89M$ -16.20M$ -26.71M$ -12.37M
Investing Cash Flow$ -3.00K$ 619.00K$ -5.16M$ -11.00K$ 0.00
Financing Cash Flow$ 14.84M$ 8.41M$ 14.02M$ 43.19M$ 13.19M
Currency in USD

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS